Brief: Thor Medical H2 EBITDA Loss At NOK 6.8 Mln
Feb 28 (Reuters) - Thor Medical ASA TRMED.OL :
* H2 EBITDA LOSS NOK 6.8 MILLION VERSUS NOK 0 YEAR AGO
* H2 LOSS FOR THE PERIOD AFTER TAX NOK 5.6 MILLION VERSUS
NOK 0
YEAR AGO
Source text for Eikon: ID:nObidqrzPa
Further company coverage: TRMED.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln